Barclays PLC Has $911,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Barclays PLC increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 390.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,473 shares of the technology company’s stock after buying an additional 22,669 shares during the period. Barclays PLC owned 0.14% of Simulations Plus worth $911,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. First Horizon Advisors Inc. grew its holdings in Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after acquiring an additional 370 shares during the period. nVerses Capital LLC lifted its stake in Simulations Plus by 1,100.0% in the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after acquiring an additional 1,100 shares in the last quarter. Quantbot Technologies LP bought a new stake in Simulations Plus during the 3rd quarter worth about $59,000. US Bancorp DE grew its stake in Simulations Plus by 37.0% in the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after purchasing an additional 1,343 shares in the last quarter. Finally, Pitcairn Co. lifted its stake in Simulations Plus by 9.1% in the third quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock valued at $211,000 after acquiring an additional 549 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $28.76 on Wednesday. Simulations Plus, Inc. has a 52-week low of $24.00 and a 52-week high of $51.22. The business’s 50 day simple moving average is $29.85 and its two-hundred day simple moving average is $33.35. The firm has a market cap of $577.85 million, a P/E ratio of 58.70 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.18 earnings per share. On average, equities analysts forecast that Simulations Plus, Inc. will post 1.1 earnings per share for the current fiscal year.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the completion of the transaction, the director now owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This represents a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 19.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. KeyCorp cut their price target on Simulations Plus from $40.00 to $35.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Stephens started coverage on Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 target price for the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. BTIG Research reduced their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, October 24th. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Simulations Plus currently has an average rating of “Moderate Buy” and an average target price of $49.00.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.